Celltrion launches AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in the United States
The AVTOZMA ® (tocilizumab-anoh) intravenous (IV) formulation was approved in January 2025 by the FDA to treat the…
Browsing Tag